Total Hydrocortisone Dosage in the Neonatal Period May Be Related to Low Developmental Quotient in Extremely Low Birth Weight Infants: A Retrospective Cohort Study

CONCLUSION: Higher total HDC dosage up to 36 weeks postmenstrual age in ELBW infants was associated with impaired neurodevelopmental outcomes. Although HDC is often needed in the treatment of ELBW infants, clinicians should be aware that an increased dose of HDC may be associated with impaired neurodevelopmental outcomes.PMID:38043512 | DOI:10.1159/000534934

Source: Neonatology - December 3, 2023 Category: Perinatology & Neonatology Authors: Akinobu Taniguchi Kazuki Nishida Toshihiko Suzuki Erina Kataoka Naozumi Fujishiro Eiko Kato Hikaru Yamamoto Koji Takemoto Miharu Ito Seiji Hayashi Yuichiro Sugiyama Takashi Maeda Yoshiyuki Takahashi Yoshiaki Sato Source Type: research